{
    "data": [
        {
            "id": 2991746,
            "title": "Wyndham Issues $650 Million Senior Notes, Refinances Debt",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Wyndham Hotels &amp; Resorts ( <a data-ticker=\"WH\" href=\"https://www.tipranks.com/stocks/wh\">(WH)</a> ) has shared an update.</p>\n<p></p>\n<p></p><p>On February 27, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Wyndham Hotels &amp; Resorts</a></span>, Inc. issued and sold $650 million of 5.625% senior unsecured notes due 2033, with interest payable semi-annually beginning September 1, 2026. The notes rank equally with the company’s existing senior debt, are guaranteed on a senior unsecured basis by certain domestic subsidiaries, and include standard covenants, change-of-control protections, and events-of-default provisions.</p>\n<p>Wyndham used the net proceeds from the offering to fully repay outstanding borrowings under its term loan A and revolving credit facility, fund related fees and expenses, and support general corporate purposes. The transaction refinances bank debt with longer-dated capital markets funding, potentially improving the company’s debt maturity profile while maintaining relationships with key lenders and initial purchasers that also participate in its credit facilities.</p>\n<p>The most recent analyst rating on <a data-ticker=\"WH\" href=\"https://www.tipranks.com/stocks/wh\">(WH)</a> stock is a Hold with a $89.00 price target. To see the full list of analyst forecasts on Wyndham Hotels &amp; Resorts stock, see the WH <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on WH Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, WH is a Neutral.</p>\n<p>The score is primarily held back by elevated balance-sheet leverage and the sharp 2025 revenue/margin deterioration despite solid cash generation. Technicals are constructive with strong trend and momentum, while valuation looks rich at a 33.24 P/E with only a modest dividend yield. Earnings-call guidance supports modest 2026 growth but highlights continued RevPAR headwinds and franchisee-related fee uncertainty.</p>\n<p>To see Spark’s full report on WH stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Wyndham Hotels &amp; Resorts</u></b></p>\n<p>Wyndham Hotels &amp; Resorts, Inc. is a lodging company that operates in the hotel and hospitality industry. The company focuses on franchising and managing hotel properties, offering accommodations across multiple brands and market segments to business and leisure travelers worldwide.</p>\n<p><b>Average Trading Volume:</b> 1,345,419</p>\n<p><b>Technical Sentiment Signal:</b> Strong Buy</p>\n<p><b>Current Market Cap:</b> $6.34B</p>\n<p></p>\n<p></p><p>See more data about WH stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/wh\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Cylical-6-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/wyndham-issues-650-million-senior-notes-refinances-debt",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 06:05:49",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991716,
            "title": "Mowi Chair Resigns; Leif Teksum Named Interim Board Leader",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Mowi ASA ( <a data-ticker=\"GB:0OAW\" href=\"https://www.tipranks.com/stocks/gb:0oaw\">(GB:0OAW)</a> ) just unveiled an update.</p>\n<p></p>\n<p></p><p>Mowi ASA announced that Ørjan Svanevik has resigned with immediate effect as Chair of the Board following the end of his employment with Seatankers Management, linked to major shareholder Geveran Trading. The nomination committee acknowledged his departure, confirmed the board still has a quorum, and appointed Vice Chair Leif Teksum as Interim Chair.</p>\n<p>Teksum, a board member since 2024, brings more than three decades of experience from DNB, including responsibility for the seafood sector, as well as board roles at companies such as Yara International and Nordic Trustee. His appointment provides continuity and sector-specific expertise at a sensitive governance juncture, helping to stabilize leadership and reassure investors under Norwegian securities disclosure rules.</p>\n<p>The most recent analyst rating on <a data-ticker=\"GB:0OAW\" href=\"https://www.tipranks.com/stocks/gb:0oaw\">(GB:0OAW)</a> stock is a Hold with a NOK220.00 price target. To see the full list of analyst forecasts on Mowi ASA stock, see the GB:0OAW <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/gb:0oaw/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>More about Mowi ASA</u></b></p>\n<p>Mowi ASA is a global seafood company and one of the world’s largest producers of farmed salmon, operating across the aquaculture value chain. The group focuses on sustainable salmon farming and related seafood products, supplying major retail and food service markets worldwide.</p>\n<p><b>Average Trading Volume:</b> 1,074,853</p>\n<p><b>Current Market Cap:</b> NOK118.1B</p>\n<p></p>\n<p></p><p>Find detailed analytics on 0OAW stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/gb:0oaw\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Consumer-Defensive-5-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/mowi-chair-resigns-leif-teksum-named-interim-board-leader",
            "author": "TipRanks European Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:56:18",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991706,
            "title": "PrimeEnergy Amends Credit Facility, Reaffirms $115 Million Base",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Primeenergy ( <a data-ticker=\"PNRG\" href=\"https://www.tipranks.com/stocks/pnrg\">(PNRG)</a> ) has issued an announcement.</p>\n<p></p>\n<p></p><p>On February 24, 2026, PrimeEnergy Resources Corporation entered into a Fifth Amendment to its Fourth Amended and Restated Credit Agreement with Citibank and other lenders, reaffirming its borrowing base at $115 million. The amendment reduces interest margins on SOFR and base-rate loans by 50 basis points at each utilization level, updates commodity hedging covenants by raising certain utilization thresholds from 25% to 30%, adjusts lender schedules, and imposes customary post-closing mortgage and title delivery obligations, while leaving core facility terms such as commitments, collateral, covenants, and maturity unchanged.</p>\n<p>As of December 31, 2025, and February 27, 2026, PrimeEnergy had no outstanding borrowings, preserving full availability under the $115 million borrowing base. The changes are expected to lower the company’s cost of capital on future draws and provide slightly more flexibility around hedging requirements, supporting its liquidity position without altering the overall structure of its revolving credit facility.</p>\n<p>The most recent analyst rating on <a data-ticker=\"PNRG\" href=\"https://www.tipranks.com/stocks/pnrg\">(PNRG)</a> stock is a Buy with a $184.00 price target. To see the full list of analyst forecasts on Primeenergy stock, see the PNRG <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/pnrg/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on PNRG Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, PNRG is a Outperform.</p>\n<p>Primeenergy’s overall stock score is driven by its strong financial position and improving cash flow generation, despite challenges in revenue and profit margins. Technical analysis indicates short-term bullish momentum but warns of potential overbought conditions. Valuation is fair, though the lack of a dividend yield may deter some investors.</p>\n<p>To see Spark’s full report on PNRG stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/pnrg/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Primeenergy</u></b></p>\n<p>PrimeEnergy Resources Corporation operates in the energy sector and utilizes a senior secured revolving credit facility to support its operations. The company’s capital structure includes a borrowing base backed by oil and gas properties, with Citibank, N.A. serving as administrative agent under its primary credit agreement.</p>\n<p><b>Average Trading Volume:</b> 54,342</p>\n<p><b>Technical Sentiment Signal:</b> Strong Buy</p>\n<p><b>Current Market Cap:</b> $300.4M</p>\n<p></p>\n<p></p><p>Learn more about PNRG stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/pnrg\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Energy-6-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/primeenergy-amends-credit-facility-reaffirms-115-million-base",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:51:04",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991699,
            "title": "Ocular Therapeutix Highlights Phase 3 AXPAXLI Trial Progress",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Ocular Therapeutix ( <a data-ticker=\"OCUL\" href=\"https://www.tipranks.com/stocks/ocul\">(OCUL)</a> ) has provided an announcement.</p>\n<p></p>\n<p></p><p>On February 27, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Ocular Therapeutix</a></span> announced that it would post investor presentation slides on its corporate website at 4:15 p.m. Eastern Time. The materials detail results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI (OTX-TKI) for the treatment of wet age-related macular degeneration, underscoring the company’s progress in advancing late-stage retinal disease therapies.</p>\n<p>The disclosure of Phase 3 data at the 49th Macula Society Annual Meeting highlights Ocular Therapeutix’s bid to strengthen its position in the competitive ophthalmology market. By sharing detailed trial outcomes with both clinicians and investors, the company is signaling a critical development milestone that could influence perceptions of its clinical pipeline and future commercial prospects.</p>\n<p>The most recent analyst rating on <a data-ticker=\"OCUL\" href=\"https://www.tipranks.com/stocks/ocul\">(OCUL)</a> stock is a Hold with a $8.00 price target. To see the full list of analyst forecasts on Ocular Therapeutix stock, see the OCUL <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on OCUL Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, OCUL is a Neutral.</p>\n<p>The score is held down primarily by weak financial performance (large and widening losses plus accelerating cash burn) and bearish technicals (below key moving averages with negative MACD). These are partially offset by a constructive earnings-call outlook centered on strong trial progress, upcoming SOL-1 data, and an extended cash runway, while valuation remains constrained by negative earnings and no dividend.</p>\n<p>To see Spark’s full report on OCUL stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Ocular Therapeutix</u></b></p>\n<p>Ocular Therapeutix, Inc. is a biopharmaceutical company focused on ophthalmology, developing therapies for eye diseases such as wet age-related macular degeneration. The company’s pipeline includes AXPAXLI (also known as OTX-TKI), designed as a treatment for retinal conditions that require long-acting, localized drug delivery.</p>\n<p><b>Average Trading Volume:</b> 5,749,145</p>\n<p><b>Technical Sentiment Signal:</b> Hold</p>\n<p><b>Current Market Cap:</b> $1.95B</p>\n<p></p>\n<p></p><p>For a thorough assessment of OCUL stock, go to <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/ocul\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_390599908-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/ocular-therapeutix-highlights-phase-3-axpaxli-trial-progress",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:46:11",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991681,
            "title": "Indaptus Shareholders Approve Major Charter and Capital Changes",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Indaptus Therapeutics ( <a data-ticker=\"INDP\" href=\"https://www.tipranks.com/stocks/indp\">(INDP)</a> ) has issued an update.</p>\n<p></p>\n<p></p><p>On February 26, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Indaptus Therapeutics</a></span> held a special shareholders’ meeting at which investors elected Jerome Jabbour as a Class I director through the 2028 annual meeting and Matthew McMurdo as a Class III director through the 2027 meeting, with approximately 34.7% of outstanding common shares represented. Stockholders also approved multiple Nasdaq-related share issuance proposals, authorizing the issuance of common stock upon conversion of Series AA and Series AAA preferred shares, including shares issuable to the company’s co-chief executive officer and chairman.</p>\n<p>Investors further backed amendments to the charter to permit two reverse stock splits at ratios between 1-for-2 and 1-for-199, to be implemented at the board’s discretion, as well as an expansion of authorized common shares from 200 million to up to 1 billion. A charter amendment to allow shareholder action by written consent in lieu of a meeting was approved and became effective via a Certificate of Amendment filed in Delaware on February 27, 2026, giving the company greater flexibility in capital raising and corporate actions while potentially increasing future dilution risk for existing shareholders.</p>\n<p>The most recent analyst rating on <a data-ticker=\"INDP\" href=\"https://www.tipranks.com/stocks/indp\">(INDP)</a> stock is a Sell with a $1.50 price target. To see the full list of analyst forecasts on Indaptus Therapeutics stock, see the INDP <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on INDP Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, INDP is a Neutral.</p>\n<p>The score is held down primarily by weak financial performance (no revenue, sizable ongoing losses, and continued cash burn alongside a diminished equity/asset base). Technicals also remain bearish with the stock trading below all major moving averages and a negative MACD, despite oversold readings. Valuation provides limited support due to negative earnings and no dividend, while recent corporate events are mixed but secondary to the financial and trend risks.</p>\n<p>To see Spark’s full report on INDP stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Indaptus Therapeutics</u></b></p>\n<p>Indaptus Therapeutics operates in the biopharmaceutical sector and is listed on Nasdaq, issuing common stock and multiple series of convertible preferred stock. The company’s governance structure includes a classified board, and its capital strategy relies on the flexibility to issue large volumes of equity and to adjust its share structure through mechanisms such as reverse stock splits.</p>\n<p><b>Average Trading Volume:</b> 715,452</p>\n<p><b>Technical Sentiment Signal:</b> Strong Sell</p>\n<p><b>Current Market Cap:</b> $4.51M</p>\n<p></p>\n<p></p><p>See more data about INDP stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/indp\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_2157214825-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/indaptus-shareholders-approve-major-charter-and-capital-changes",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:40:12",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991667,
            "title": "Comcast Expands Board Oversight with New Audit Committee Appointment",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>An announcement from Comcast ( <a data-ticker=\"CMCSA\" href=\"https://www.tipranks.com/stocks/cmcsa\">(CMCSA)</a> ) is now available.</p>\n<p></p>\n<p></p><p><span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/cmcsa\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Comcast</a></span> said that on February 25, 2026, its board of directors appointed Gordon Smith to serve on the board’s Audit Committee, following his earlier appointment as a director on February 4, 2026. The move signals Comcast’s continued focus on board-level financial oversight and governance, which may influence how the company manages risk, compliance and financial reporting for investors and other stakeholders.</p>\n<p>The most recent analyst rating on <a data-ticker=\"CMCSA\" href=\"https://www.tipranks.com/stocks/cmcsa\">(CMCSA)</a> stock is a Sell with a $27.00 price target. To see the full list of analyst forecasts on Comcast stock, see the CMCSA <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/cmcsa/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on CMCSA Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, CMCSA is a Outperform.</p>\n<p>The score is driven primarily by strong financial performance (healthy margins and robust free cash flow) and very compelling valuation (low P/E and high dividend yield). Technicals are moderately supportive with positive momentum. The main constraint is earnings-call guidance pointing to near-term broadband and segment EBITDA pressure and less favorable cash-tax benefits in 2026.</p>\n<p>To see Spark’s full report on CMCSA stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/cmcsa/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Comcast</u></b></p>\n<p>Comcast Corporation is a global media and technology company operating in the telecommunications and entertainment industries, best known for its cable and broadband services as well as content production and distribution. The company serves residential and business customers through its communications networks and media platforms, competing with other major telecom and streaming providers.</p>\n<p><b>Average Trading Volume:</b> 35,496,392</p>\n<p><b>Technical Sentiment Signal:</b> Hold</p>\n<p><b>Current Market Cap:</b> $113.7B</p>\n<p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/12/shutterstock_2148870733.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/comcast-expands-board-oversight-with-new-audit-committee-appointment",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:35:05",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991640,
            "title": "Akanda’s First Towers & Fiber to Ramp Up Leasing of Central Mexico Dark Fiber Network",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>The latest update is out from Akanda Corp ( <a data-ticker=\"AKAN\" href=\"https://www.tipranks.com/stocks/akan\">(AKAN)</a> ).</p>\n<p></p>\n<p></p><p>Akanda Corp., through its wholly owned Mexican subsidiary First Towers &amp; Fiber Corp., operates what it describes as the largest dark fiber optic network in Central Mexico, spanning roughly 700 kilometres and serving major industrial corridors and high-growth state economies. The infrastructure is anchored by a 20-year lease with Telefónica, which currently uses only a small portion of the network’s 24 available fiber pairs, alongside capacity leased to Marcatel.</p>\n<p>In a February 27, 2026 announcement, Akanda and FTF outlined plans to expand leasing of this underutilized dark fiber network starting in 2026, aiming to add more tenants and boost recurring revenue with limited additional capital outlay. Management argues that the network’s scale, redundancy and available capacity position FTF as a key shared infrastructure provider for rising connectivity demand in Central Mexico, with potential implications for the region’s telecom competition and for Akanda’s long-term revenue mix.</p>\n<p><b><u>More about Akanda Corp</u></b></p>\n<p>First Towers &amp; Fiber Corp. is an emerging telecommunications infrastructure developer in Mexico, focused on cellular tower construction and dark fiber networks. The company partners with national carriers and technology providers to deliver scalable, reliable connectivity solutions that support commercial growth and digital inclusion in fast-growing regional markets.</p>\n<p><b>Average Trading Volume:</b> 1,376,505</p>\n<p><b>Technical Sentiment Signal:</b> Sell</p>\n<p><b>Current Market Cap:</b> $1.85M</p>\n<p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_296599349-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/akandas-first-towers-fiber-to-ramp-up-leasing-of-central-mexico-dark-fiber-network",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 05:17:17",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991595,
            "title": "Netflix Receives Termination Fee After WBD Deal Collapse",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Netflix ( <a data-ticker=\"NFLX\" href=\"https://www.tipranks.com/stocks/nflx\">(NFLX)</a> ) just unveiled an update.</p>\n<p></p>\n<p></p><p>On January 19, 2026, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/nflx\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Netflix</a></span> entered into an amended merger agreement under which it would have acquired a reorganized Warner Bros. Discovery entity holding the company’s Streaming &amp; Studios businesses, leaving WBD’s Global Linear Networks and certain other assets separated. This structure was designed to make the retained WBD streaming and studio operations a wholly owned Netflix subsidiary, supported by a package of committed bridge and term financing arrangements.</p>\n<p>However, on February 26, 2026, Warner Bros. Discovery notified Netflix that a revised offer from Paramount Skydance Corporation constituted a superior proposal under the merger agreement. Netflix waived its right to negotiate changes, and on February 27, 2026, WBD terminated the deal with Netflix to sign a merger agreement with Paramount Skydance, triggering a $2.8 billion termination fee payable to Netflix.</p>\n<p>Concurrent with the termination of the merger agreement on February 27, 2026, all related financing commitments arranged by Netflix, including a bridge commitment letter, incremental bridge facility, a 2025 revolving credit facility and a delayed draw term loan, were automatically canceled. These facilities had been intended to fund the proposed acquisition and associated costs, so their termination effectively unwinds the capital structure Netflix had put in place for the abandoned transaction.</p>\n<p>The most recent analyst rating on <a data-ticker=\"NFLX\" href=\"https://www.tipranks.com/stocks/nflx\">(NFLX)</a> stock is a Buy with a $120.00 price target. To see the full list of analyst forecasts on Netflix stock, see the NFLX <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/nflx/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on NFLX Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, NFLX is a Outperform.</p>\n<p>Strong underlying fundamentals (high margins, robust free cash flow, and improving leverage) and constructive 2026 guidance support the score. However, very weak technical momentum (below key moving averages with oversold indicators) is a major near-term risk, and the relatively high P/E leaves less room for disappointment.</p>\n<p>To see Spark’s full report on NFLX stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/nflx/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Netflix</u></b></p>\n<p>Netflix, Inc. is a global entertainment company operating primarily in the streaming media and film and television production industry. The company offers subscription-based streaming services delivering on-demand series, films and documentaries worldwide, and increasingly competes on large-scale content and strategic transactions to strengthen its position against major media and tech rivals.</p>\n<p><b>Average Trading Volume:</b> 47,227,069</p>\n<p><b>Technical Sentiment Signal:</b> Hold</p>\n<p><b>Current Market Cap:</b> $329.5B</p>\n<p></p>\n<p></p><p>See more insights into NFLX stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/nflx\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2023/06/Communication-Services-10-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/netflix-receives-termination-fee-after-wbd-deal-collapse",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 04:48:41",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991554,
            "title": "Biophytis Doubles Hexagon Bond Facility to €2 Million and Extends Maturity",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Biophytis ( <a data-ticker=\"BPTSY\" href=\"https://www.tipranks.com/stocks/bptsy\">(BPTSY)</a> ) has shared an update.</p>\n<p></p>\n<p></p><p>On February 27, 2026, Biophytis announced amendments to its bond financing agreement with Hexagon Capital Fund, doubling the maximum nominal amount from €1 million to €2 million and extending the subscription period from July 31, 2026 to December 31, 2027. The move increases the company’s drawing capacity to €1.35 million as of February 26, 2026, extends its cash runway by about four months, and is framed by management as a vote of confidence in its strategy and late-stage clinical programs in obesity and sarcopenia.</p>\n<p>Under the revised terms, each bond bears 12% interest and is redeemable in cash on a bi-monthly schedule over 24 months, while in a default scenario the debt could be repaid in shares at a fixed premium price, implying potential but limited dilution for existing shareholders. Backing from Hexagon Capital Fund, which specializes in financing European SMEs via bonds and equities, underscores continued institutional support for Biophytis at a capital-intensive stage of development, giving the biotech added financial flexibility to advance its pipeline in high unmet-need indications.</p>\n<p>The most recent analyst rating on <a data-ticker=\"BPTSY\" href=\"https://www.tipranks.com/stocks/bptsy\">(BPTSY)</a> stock is a Hold with a $0.65 price target. To see the full list of analyst forecasts on Biophytis stock, see the BPTSY <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/bptsy/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on BPTSY Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, BPTSY is a Neutral.</p>\n<p>The score is primarily held down by weak financial performance (no revenue, ongoing cash burn, and negative equity), reinforced by bearish technicals with the stock trading below major moving averages. Valuation is also constrained by negative earnings and no dividend support, with only a minor offset from oversold momentum readings.</p>\n<p>To see Spark’s full report on BPTSY stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/bptsy/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Biophytis</u></b></p>\n<p>Biophytis SA is a clinical-stage biotechnology company developing drug candidates for age-related diseases, with a lead molecule BIO101 targeting muscular conditions such as sarcopenia and Duchenne muscular dystrophy, respiratory diseases including COVID-19, and metabolic disorders like obesity. Headquartered in Paris with subsidiaries in Cambridge, Massachusetts and Brazil, the company is listed on Euronext Growth Paris and its ADS trade on the U.S. OTC market.</p>\n<p><b>Average Trading Volume:</b> 754</p>\n<p><b>Technical Sentiment Signal:</b> Strong Sell</p>\n<p><b>Current Market Cap:</b> $2.56M</p>\n<p></p>\n<p></p><p>See more insights into BPTSY stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/bptsy\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_1561815367-1-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/biophytis-doubles-hexagon-bond-facility-to-e2-million-and-extends-maturity",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 04:27:20",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        },
        {
            "id": 2991546,
            "title": "Banco Macro Calls April 8, 2026 Shareholders’ Meeting to Approve Earnings Allocation and Dividend Plan",
            "description": "<html><head></head><body><p></p><p></p><h3 style=\"text-decoration: underline; text-decoration-color: #1e77f9;\"><a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\">Claim 50% Off TipRanks Premium</a></h3><ul style=\"padding-top: 5px;\"><li>Unlock <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> hedge fund-level data </a> and <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> powerful investing tools </a> for smarter, sharper decisions \n</li><li> Stay ahead of the market with <a data-link=\"article_promo\" href=\"https://www.tipranks.com/checkout/v2?subscription=tipranks-premium-yearly&amp;llf=rss&amp;coupon=INTRO50P&amp;checkoutPage=checkoutv2\"> the latest news and analysis </a> and maximize your portfolio's potential</li></ul><p></p><p>Banco Macro SA ( <a data-ticker=\"BMA\" href=\"https://www.tipranks.com/stocks/bma\">(BMA)</a> ) has shared an update.</p>\n<p></p>\n<p></p><p>Banco Macro S.A.’s board has called a general shareholders’ meeting for April 8, 2026, to be held in hybrid format in Buenos Aires and via Zoom, to review the financial statements and governance performance for the fiscal year ended December 31, 2025. Shareholders will also vote on board and supervisory committee remuneration, appoint new directors, define the composition of the supervisory committee, and select independent auditors for the 2026 fiscal year.</p>\n<p>The agenda includes applying AR$290.44 billion in retained earnings from 2025, with allocations to the legal reserve, tax obligations and an optional reserve fund, and proposes carving out AR$300 billion from optional reserves to finance a substantial dividend in cash, in kind or a mix, subject to prior central bank approval and local tax withholding. The decisions to be taken could materially influence Banco Macro’s capital allocation, shareholder returns and governance structure, while the detailed remote-participation rules and eligibility criteria underscore the company’s efforts to ensure regulatory compliance and broad investor access.</p>\n<p>The most recent analyst rating on <a data-ticker=\"BMA\" href=\"https://www.tipranks.com/stocks/bma\">(BMA)</a> stock is a Buy with a $98.00 price target. To see the full list of analyst forecasts on Banco Macro SA stock, see the BMA <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/bma/forecast\" target=\"_blank\" ;=\"\" rel=\"nofollow\">Stock Forecast page</a></span>.</p>\n<p><b><u>Spark’s Take on BMA Stock</u></b></p>\n<p>According to Spark, TipRanks’ <a data-autolink=\"true\" href=\"https://www.tipranks.com/compare-stocks/artificial-intelligence\">AI</a> Analyst, BMA is a Neutral.</p>\n<p>Banco Macro’s overall stock score reflects a mix of strong revenue growth and a solid balance sheet, tempered by modest profitability and significant challenges highlighted in the recent earnings call. Technical indicators show positive momentum, but the financial performance and earnings call concerns weigh heavily on the score.</p>\n<p>To see Spark’s full report on BMA stock, <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/bma/ai-stock-analysis\" target=\"_blank\" ;=\"\" rel=\"nofollow\">click here</a></span>. </p>\n<p><b><u>More about Banco Macro SA</u></b></p>\n<p>Banco Macro S.A., operating as Macro Bank Inc. for its U.S.-listed securities, is an Argentine financial institution headquartered in Buenos Aires. It provides a broad range of banking services in the local market, with operations regulated by the Central Bank of the Republic of Argentina and overseen by the Argentine Securities Exchange Commission.</p>\n<p><b>Average Trading Volume:</b> 278,469</p>\n<p><b>Technical Sentiment Signal:</b> Buy</p>\n<p><b>Current Market Cap:</b> $5.97B</p>\n<p></p>\n<p></p><p>Learn more about BMA stock on <span class=\"tr-stock-ticker\" style=\"color:blue\"><a href=\"https://www.tipranks.com/stocks/bma\" target=\"_blank\" ;=\"\" rel=\"nofollow\">TipRanks’ Stock Analysis page</a></span>.</p><p></p>",
            "image": "https://blog.tipranks.com/wp-content/uploads/2022/09/shutterstock_422682820-750x406.jpg",
            "link": "https://www.tipranks.com/news/company-announcements/banco-macro-calls-april-8-2026-shareholders-meeting-to-approve-earnings-allocation-and-dividend-plan",
            "author": "TipRanks Auto-Generated Newsdesk",
            "pub_date": "2026-02-28 04:17:21",
            "source": "tipranks_announcements",
            "kind": 1,
            "language": "en"
        }
    ]
}